# Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

> **NCT06119256** · PHASE1 · RECRUITING · sponsor: **Chinese PLA General Hospital** · enrollment: 12 (estimated)

## Conditions studied

- EBV Infection After Allogenic HSCT

## Interventions

- **BIOLOGICAL:** EBV-TCR-T cells

## Key facts

- **NCT ID:** NCT06119256
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06119256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06119256, "Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06119256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*